Sale!

JAK2 Gene Polycythemia Vera Somatic NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The JAK2 Gene Polycythemia Vera Somatic NGS Genetic DNA Test is a cutting-edge diagnostic tool that detects specific mutations in the JAK2 gene associated with Polycythemia Vera and other myeloproliferative neoplasms. Using Next-Generation Sequencing (NGS) technology, this test provides comprehensive analysis of somatic mutations that drive abnormal blood cell production. The test is essential for patients experiencing unexplained elevated red blood cell counts, persistent itching after bathing, fatigue, or other symptoms suggestive of blood disorders. Results help guide targeted treatment decisions and provide crucial diagnostic confirmation. Available for only $500 USD, this advanced genetic testing offers precise molecular insights for optimal patient care and management strategies.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

JAK2 Gene Polycythemia Vera Somatic NGS Genetic DNA Test

Comprehensive Introduction to JAK2 Genetic Testing

The JAK2 Gene Polycythemia Vera Somatic NGS Genetic DNA Test represents a breakthrough in molecular diagnostics for blood disorders. This advanced genetic analysis specifically targets the JAK2 (Janus Kinase 2) gene, which plays a critical role in regulating blood cell production. When mutations occur in this gene, they can trigger uncontrolled cell growth leading to Polycythemia Vera and related myeloproliferative neoplasms. Our state-of-the-art Next-Generation Sequencing technology provides unparalleled accuracy in detecting these somatic mutations, offering patients and healthcare providers definitive diagnostic information for personalized treatment planning.

What This Test Measures and Detects

This sophisticated genetic test specifically identifies somatic mutations in the JAK2 gene, particularly focusing on:

  • JAK2 V617F mutation – the most common mutation associated with Polycythemia Vera
  • Other JAK2 exon 12 mutations that can cause similar blood disorders
  • Somatic genetic alterations that drive abnormal blood cell proliferation
  • Mutation burden and variant allele frequency for treatment monitoring

The NGS methodology employed ensures comprehensive coverage of the entire JAK2 gene coding region, providing a complete molecular profile that traditional testing methods might miss.

Who Should Consider JAK2 Genetic Testing

This test is recommended for individuals experiencing symptoms suggestive of myeloproliferative disorders, including:

  • Unexplained elevated red blood cell counts (erythrocytosis)
  • Persistent itching, especially after warm baths or showers (aquagenic pruritus)
  • Fatigue, weakness, or unexplained weight loss
  • Headaches, dizziness, or visual disturbances
  • Enlarged spleen (splenomegaly) detected during physical examination
  • Abnormal blood clotting or bleeding tendencies
  • Family history of blood disorders or previous inconclusive test results

Significant Benefits of JAK2 Genetic Testing

Undergoing JAK2 genetic testing provides numerous advantages for patients and healthcare providers:

  • Definitive Diagnosis: Provides conclusive evidence for Polycythemia Vera diagnosis
  • Personalized Treatment: Guides targeted therapy decisions with JAK inhibitors
  • Prognostic Information: Helps predict disease progression and complications
  • Family Planning: Distinguishes between acquired and inherited conditions
  • Treatment Monitoring: Tracks mutation burden during therapy
  • Early Intervention: Enables timely management to prevent complications

Understanding Your Test Results

Your JAK2 genetic test results will be carefully interpreted by our team of genetic specialists and oncologists:

  • Positive Result: Indicates the presence of JAK2 mutations, confirming Polycythemia Vera or related disorders
  • Negative Result: Suggests absence of common JAK2 mutations, though other genetic testing may be recommended
  • Variant of Uncertain Significance: Rare genetic changes requiring additional clinical correlation
  • Mutation Burden: Quantitative assessment of mutation percentage for treatment planning

All results include comprehensive consultation with our genetic counselors to ensure complete understanding and appropriate next steps.

Test Pricing and Details

Test Component Details
Test Name JAK2 Gene Polycythemia Vera Somatic NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Specialty Oncology Genetics

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified collection centers ensures easy access to this vital genetic testing regardless of your location.

Take Control of Your Health Today

Don’t let uncertainty about blood disorders compromise your health and quality of life. The JAK2 Gene Polycythemia Vera Somatic NGS Genetic DNA Test provides the clarity needed for accurate diagnosis and effective treatment planning. Our team of genetic specialists and oncologists are ready to guide you through every step of the testing process.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your test or speak with our genetic counseling team. Take the first step toward definitive diagnosis and personalized care.